-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BeaRsUbA499usVVNmW9dviwckzSodDqAsh107WQupmZkk2PDa5qpxrS/UzGfH8Xv Yn8pcoNoJGThsPjAcQoZBg== 0000878088-08-000005.txt : 20080109 0000878088-08-000005.hdr.sgml : 20080109 20080109154048 ACCESSION NUMBER: 0000878088-08-000005 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080107 FILED AS OF DATE: 20080109 DATE AS OF CHANGE: 20080109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PAR PHARMACEUTICAL COMPANIES, INC. CENTRAL INDEX KEY: 0000878088 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223122182 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 TICE BOULEVARD CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 BUSINESS PHONE: 201-802-4000 MAIL ADDRESS: STREET 1: 300 TICE BOULEVARD CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 FORMER COMPANY: FORMER CONFORMED NAME: PHARMACEUTICAL RESOURCES INC DATE OF NAME CHANGE: 19940526 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NORDMANN RONALD M CENTRAL INDEX KEY: 0001189790 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10827 FILM NUMBER: 08520557 BUSINESS ADDRESS: STREET 1: 121 GLEN ROCK ROAD CITY: LITTLE FALLS STATE: NJ ZIP: 07424 4 1 primary_doc.xml PRIMARY DOCUMENT X0202 4 2008-01-07 0 0000878088 PAR PHARMACEUTICAL COMPANIES, INC. PRX 0001189790 NORDMANN RONALD M C/O PAR PHARMACEUTICAL COMPANIES INC. 300 TICE BLVD WOODCLIFF LAKE NJ 07677 1 0 0 0 Restricted Stock Units 0 2008-01-07 4 A 0 4406 0 A 2009-01-07 Common Stock 4406 11906 D Pursuant to the Amended and Restated 1997 Directors' Stock and Deferred Fee Plan, the Reporting Person was granted a Restricted Stock Award of the number of shares of the Issuer's common stock having an aggregate Fair Market Value equal to $100,000 on the date of grant. The Fair Market Value of each Restricted Stock Unit is equal to the closing price of the Issuer's common stock as reported by The New York Stock Exchange, Inc. on the date of grant, which was $22.70. Each stock unit is the economic equivalent of one share of common stock, but the shares of common stock are distributed only upon termination of the Reporting Person's services as a director of the Issuer. /s/ Marian E. Gustafson for Ronald M. Nordmann 2008-01-09 -----END PRIVACY-ENHANCED MESSAGE-----